Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

GREY:BIOAF - Post Discussion

biOasis Technologies Ord Shs > have dots been connected yet, jd??
View:
Post by zwerp2000 on Jan 02, 2025 5:37pm

have dots been connected yet, jd??

just wondering
Comment by InitiumMMXXIII on Jan 02, 2025 7:45pm
In any set of dots, are they not inherently connected by that association? The better question may be, are there any missing dots, and if so, to what do they relate? Should they be inserted and the set renumbered, or should they just be randomly added to the end? Is the set chaotic, zwerp, or can it be treated as a cellular atomaton? If so, is it forward deterministic? For infinite ...more  
Comment by TheTruth1234 on Jan 03, 2025 11:32am
This post has been removed in accordance with Community Policy
Comment by TheTruth1234 on Jan 03, 2025 12:37pm
Johnny boy cried to SH and got my post removed. LMFAO!!!!! Truth hurt Johnny boy?
Comment by InitiumMMXXIII on Jan 03, 2025 2:23pm
Hah! I didn't even see your post, TT, so I don't know why it was deleted. You must have used a word or phrasing that couldn't get past SH's automated censor algorithms. But the problem for you is larger than that. You only have a couple of posts in your quip file, TT, and even they are reworded versions of each other. Everyone here pretty much can guess the nature of your deleted ...more  
Comment by zwerp2000 on Jan 03, 2025 2:24pm
for years you claimed to be connecting the dots while the rest of us were too blind to see the big picture. were the dots you were connecting leading to a bankrupt company and a failed/useless platform? if so, congrats! dots connected perfectly LOL i am sure 15+ years of your life weren't wasted here
Comment by InitiumMMXXIII on Jan 03, 2025 2:47pm
Yeah, predictions of the future of Bioasis turned out to be difficult for everybody, zwerp. UBC, NRC, Janssen, Shire, Chiesi, Denali, MidaTech, Ladenburg Thalmann, XOMA, they all got it wrong. All the directors like Saltarelli, Radhakrishnan and Stagliano got it wrong, not to mention executives like Antalik, Hill, Orfali and others. I am honoured to have been in the company of ...more  
Comment by TheTruth1234 on Jan 03, 2025 4:32pm
Why did Chiesi quit? Did xB3 fail or was there something else? Because it xb3 did not work as they hoped. Chiesi did not want to waste any more money on a technology that was useless. 
Comment by InitiumMMXXIII on Jan 03, 2025 4:42pm
Too obvious, TT, not much thought given there. It conflicts with the entire history of Bioasis and xB3. Could be true but, unlike with xB3, there is public information that may suggest a different scenario. You may want to dig deeper, TheTruth1234, so that you might actually stumble upon The Truth. jd 
Comment by zwerp2000 on Jan 03, 2025 7:02pm
You may want to dig deeper, TheTruth1234, so that you might actually stumble upon The Truth. What is the truth? You're just throwing out comments without backing anything up to suggest that there was really more to the bti story.  Here's the truth, JD. XB3 was a failure. Yeah, some big pharma companies took a look at it and deemed it useless which is why they all passed on it. This ...more  
Comment by TheTruth1234 on Jan 03, 2025 7:26pm
Well said zwerp!
Comment by InitiumMMXXIII on Jan 03, 2025 7:29pm
Obviously you don't know how things work, zwerp. There's so much more that you're obviously not aware of.   You say that I am making unsupported statements and yet you say that xB3 failed.   Ok, back that up.   Give us the links.    If you can't, then give us the links about HOW xB3 might fail. Here's a clue. I posted links that make ...more  
Comment by zwerp2000 on Jan 03, 2025 8:18pm
The company failed. They are no longer operating. Several bigger pharma companies tested their technology and passed. No one had any interest in moving their technology forward. There is your evidence. I am not sure what other evidence you are looking for. I think it's been you who just doesn't get it. 
Comment by TheTruth1234 on Jan 03, 2025 7:23pm
Too obvious, TT, not much thought given there. It conflicts with the entire history of Bioasis and xB3.   Could be true but, unlike with xB3, there is public information that may suggest a different scenario.   You may want to dig deeper, TheTruth1234, so that you might actually stumble upon The Truth     Well folks, there goes ol' Johnny boy again!!    ...more  
Comment by InitiumMMXXIII on Jan 03, 2025 7:31pm
Well, TT, it's obvious that I did a lot more work than you did on xB3. Laffer, that one.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities